DNTH icon

Dianthus Therapeutics

94 hedge funds and large institutions have $217M invested in Dianthus Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-1
Holders Change %
-1.05%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
17
Increased
34
Reduced
16
Closed
18
Calls
$3K
Puts
$89K
Net Calls
-$86K
Net Calls Change
+$27K
Name Holding Trade Value Shares
Change
Shares
Change %
MIM
101
Monashee Investment Management
Massachusetts
-$751K -6,250 Closed
OM
102
Opaleye Management
Massachusetts
-$385K -3,202 Closed
CCM
103
CAAS Capital Management
New York
-$376K -3,125 Closed
LCM
104
Laurion Capital Management
New York
-$334K -2,787 Closed
ECM
105
ExodusPoint Capital Management
New York
-$329K -2,736 Closed
TI
106
Trexquant Investment
Connecticut
-$174K -1,448 Closed
B
107
Bailard
California
-$150K -1,250 Closed
Ensign Peak Advisors
108
Ensign Peak Advisors
Utah
-$95K -792 Closed
PP
109
Paloma Partners
Connecticut
-$84K -697 Closed
SG Americas Securities
110
SG Americas Securities
New York
-$76K -631 Closed
IC
111
Ikarian Capital
Texas
-$65K -542 Closed